Bearish flow noted in Teva (TEVA) with 8,983 puts trading, or 3x expected. Most active are Dec-24 16 puts and Dec-24 15.5 puts, with total volume in those strikes near 7,300 contracts. The Put ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in immunology and immuno-oncology programs with Teva Pharmaceuticals. Immunology is ...

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Teva Pharmaceutical (NYSE:TEVA) gained in the premarket trading on Wednesday after the generic drugmaker reported better-than-expected Q3 2024 financials and raised its full-year outlook ...

BRUSSELS — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...

Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year, or ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA-0.99%decrease; red down pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...

To do that, Teva conducted a "disparagement campaign" against Synthon, the only other company with an authorised drug in Europe containing glatiramer acetate, the Commission said in a statement.